Apixaban is a novel oral anticoagulant approved by the US Food and Drug Administration (FDA) in 2012 for use in patients with nonvalvular atrial fibrillation to reduce the risk of stroke and blood clots. Later, in 2014, apixaban gained approval for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), as well as for reducing the risk of blood clots (DVT and PE) in patients who have undergone knee or hip replacement surgery. The drug is also approved for reducing the risk of recurrent DVT and PE after initial therapy. This activity outlines the indications, mechanism of action, safe administration, adverse effects, contraindications, monitoring, overdose management, and toxicity of apixaban, thereby providing clinicians with a robust understanding of apixaban for treating various conditions and facilitating informed decision-making. This activity emphasizes that premature apixaban discontinuation heightens thrombotic event risks, necessitating consideration of alternative anticoagulants. By addressing these significant topics, this activity aims to enhance the proficiency and competence of healthcare professionals in managing apixaban therapy, thereby leading to improved patient outcomes.
- Provider:StatPearls, LLC
- Activity Link: https://www.statpearls.com/ArticleLibrary/viewarticle/35631
- Start Date: 2023-09-01 05:00:00
- End Date: 2023-09-01 05:00:00
- Credit Details: IPCE Credits: 1.5 hours
AMA PRA Category 1 Credit™️: 1.5 hours
Nursing: 1.5 hours
Pharmacy: 1.5 hours - MOC Credit Details: ABS - 1.5 Point; Credit Type(s): Accredited CME (ABS)
ABOS - 1.5 Point; Credit Type(s): Accredited CME (ABOS)
ABPATH - 1.5 Point; Credit Type(s): Lifelong Learning (ABPATH)
ABA - 1.5 Point; Credit Type(s): Lifelong Learning (ABA)
ABTS - 1.5 Point; Credit Type(s): Accredited CME (ABTS)
ABIM - 1.5 Point; Credit Type(s): Medical Knowledge (ABIM)
ABS - 1.5 Point; Credit Type(s): Self-Assessment (ABS)
ABP - 1.5 Point; Credit Type(s): Lifelong Learning and Self-Assessment (ABP)
ABTS - 1.5 Point; Credit Type(s): Self-Assessment (ABTS) - Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Variable
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Adolescent Medicine, Ambulatory/Outpatient, Cardiac Anesthesia, Cardiothoracic, Cardiovascular, Cardiovascular Disease, Clinical Pathology, Critical Care Medicine, General Operative Anesthesia, General Orthopaedics, General Pediatrics, General Surgery, General Thoracic, Hematology, Hematology (Blood, BM), Hemostasis & Thrombosis/Coagulation, Hospital Medicine, Internal Medicine, Interventional Cardiology, Neurocritical Care, Pediatric Cardiology, Pediatric Critical Care Medicine, Pediatric Emergency Medicine, Pediatric Hematology-Oncology, Pediatric Pulmonology, Pulmonary Disease, Surgical Critical Care, Thoracic Anesthesia, Vascular Surgery